Misplaced Pages

Botiacrine

Clinical data
Other names	Mo 876; DMA
Identifiers
IUPAC name S- 9,9-dimethylacridine-10-carbothioate
CAS Number	4774-53-2
PubChem CID	71202
ChemSpider	64338
UNII	032WJR708Q
ChEMBL	ChEMBL2106109
CompTox Dashboard (EPA)	DTXSID60963925
Chemical and physical data
Formula	C20H24N2OS
Molar mass	340.49 g·mol
3D model (JSmol)	Interactive image
SMILES CC1(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)SCCN(C)C)C
InChI InChI=1S/C20H24N2OS/c1-20(2)15-9-5-7-11-17(15)22(18-12-8-6-10-16(18)20)19(23)24-14-13-21(3)4/h5-12H,13-14H2,1-4H3 Key:QXRUCDDVUMKOPI-UHFFFAOYSA-N

Botiacrine (INNTooltip International Nonproprietary Name; developmental code name Mo 876) is a drug of the tricyclic family described as an antiparkinsonian agent which was either never marketed or was possibly marketed outside of the United States. It was first described in the literature by 1965. The drug is an acridine derivative and is structurally related to the tricyclic antidepressant dimetacrine.

References

1. ^ Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 170. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
2. Negwer, M. (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akad.-Verlag. p. 1768. ISBN 978-3-05-500156-7. Retrieved 20 October 2024.
3. Unlisted Drugs. Unlisted Drugs Committee of the Pharmaceutical Section, Science-Technology Group, Special Libraries Association. 1977. pp. 112–113. Retrieved 20 October 2024.
4. "BOTIACRINE". Inxight Drugs. Retrieved 20 October 2024.
5. Publishing, W.A.W.A. (2013). Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. William Andrew. pp. 657–658. ISBN 978-0-8155-1856-3. Retrieved 20 October 2024.

This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Abandoned drugs
• Acridines
• Amines
• Antiparkinsonian agents
• Tricyclic compounds
• Benzoquinolines
• Thiocarbamates
• Nervous system drug stubs